Immune Thrombocytopenia (ITP) is a rare autoimmune disorder that affects the blood cells responsible for clotting, called platelets. In ITP, the immune system mistakenly attacks and destroys platelets, leading to a decreased platelet count and an increased risk of bleeding. The global market for ITP treatment is a dynamic and evolving landscape, with factors such as...
